|
|
Article: Rapid Uptake of LEVITRA(R) (vardenafil HCl) Seen Among U.S. Men with Erectile Dysfunction.
- Article from:
- PR Newswire
- Article date:
- November 21, 2003
CopyrightCOPYRIGHT 2003 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
LEVITRA(R) (vardenafil HCl) (pronounced luh-VEE-tra) is rapidly capturing a growing percentage of new prescriptions in the oral erectile dysfunction (ED) treatment market, according to data from Verispan Source Prescription Audit (SPA) [formerly called Scott Levin]. In the weeks since Levitra became available in the U.S., more than 1.5 million Levitra pills have been dispensed nationwide.(1) Levitra is co-developed and co-promoted by Bayer AG (DAX and NYSE: BAY) and GlaxoSmithKline plc (LSE and NYSE: GSK).
Recent results from two independent, comparative European studies conducted to evaluate patient preference for the three oral ED treatment options indicated ...